School of Medicine Coronavirus Update:
Read for more details specific to medical students and School of Medicine events.

Master of Science (M.S) Clinical and Translational Science

Clinical and Translational Science Overview 

Translational science is the application of the results from the basic research on cells and animals to the treatment of patients. With rapid developments in technology and genomics, this translational science is changing the advancement of medical care so that prevention and treatment of disease is specific to each individual patient. Much of this personalized medicine is dependent on clinical and translational sciences (CTS). 

Marshall University Joan C. Edwards School of Medicine (JCESOM) equips CTS M.S. students with the information and training necessary to translate basic advances into improved patient care that will enhance the quality of life for patients in the Appalachian region, particularly southern West Virginia. Marshall’s CTS M.S. program has expanded to meet both the needs of our students and the demands of our economy. Graduates of Marshall’s CTS M.S. program will be able to lead all aspects of clinical trials of new drugs and procedures. This program provides an emphasis on conducting clinical trials and research specific to the rural regions of West Virginia.

Marshall is now providing three areas of emphasis within the program: Clinical Trials, Clinical Research (Health-Related Professional School Preparation), and Clinical Informatics.


Contact Us

Submit form below with any questions you have about the program.

Minimum Admission Requirements 

  • Baccalaureate degree from an accredited college or university. 
  • Minimum 3.0 GPA overall with a 3.0 for combined science and math courses is recommended.
    • Under certain circumstances, the minimum GPA requirement may be waived on a case-by-case basis. 
  • Completion of all prerequisite coursework with a grade "C" or better.
  • No entrance exam required. 

Prerequisite Coursework 

  • Two semesters of general biology and associated laboratories.
  • Two semesters of general chemistry and associated laboratories.
  • Two semesters of organic chemistry and associated laboratories.
  • Two semesters of physics and associated laboratories.
  • One semester of biochemistry or cell biology are highly recommended but not required. 

Application Process 

  • Submit the Clinical and Translational Science M.S. application and supporting documents on BioMedCas Applicant Portal
    • When creating BioMedCas account, select 2020-2021 cycle  
  • Supporting Documents required: 
    • Official Transcripts 
    • Written Statement 
      • Your statement should address your educational and career goals, and why you should be admitted to the Clinical and Translational Science M.S. program. 
    • Three Letters of Recommendation 
      • Letters of recommendation from STEM-related Professors preferred.  
      • Recommendation requests can be found under "Supporting Information" of BioMedCas application. 
    • Resume or CV
    • International Students, will need to submit proof of English Proficiency. Visit https://www.marshall.edu/admissions/graduate-proof-of-english-proficiency/ to learn more.
  • Pay $80 application fee on BioMedCas Applicant Portal. 
  • Deadline to apply for International Students is March 15th. 

Apply NOW!

Depending on funding, a limited number of scholarships may be available for CTS MS students. Each scholarship is in the amount of a full year (fall, spring and summer terms) of in-state tuition and fees for the program. Metro, Non-WV residents and international students are eligible for the scholarship; however, the amount provided will remain the same.

This is not a tuition remission or a full scholarship, so students may want to contact the Assistant Director of Student Financial Assistance, Cindy Canterberry, MS, at 304-691-8739 or via email at madden2@marshall.edu.

For information on cost of attendance visit, marshall.edu/tuition/. For additional financial aid information, visit Marshall University's Financial Aid website or contact the financial aid office to speak with a representative. 

Old Main, Room 116
304-696-3162
sfa@marshall.edu

All students are required to meet the general requirements of the Graduate College for receipt of a master's degree. A minimum of 36 credit hours is required for a non-thesis degree. In addition, all students must pass a written and/or oral comprehensive exam. All students will take the following courses within their area of emphasis. 

Students will learn all aspects of administering a clinical trial including study design, research operations, regulatory requirements, recruiting techniques, rural health disparities and more.

CTS Core Courses  
Course Number Course Name Credit Hours
CTS 600 Epidemiology and Biostatistics Used in Medical Research 3
CTS 614 Online Survey Tools, Relational and Data Warehousing and Data Manipulation 3
CTS 620 Basic Clinical Research Operations 3
CTS 640* Clinical Trials Journal Club* (x4) 1
CTS 660 Molecular Phenotype of Appalachian Disorders 3
BMR 680* Seminar* (x4) 1
Area of Emphasis in Clinical Trials Courses
CTS 610 Study Design and Applied Statistics in Medical Research 3
CTS 625 Clinical Research Operations Lab 5
CTS 630 Fundamentals of Team Science   2
CTS 635 Writing and Peer Review of Scientific Publications 1
CTS 650 Rural Clinic Experience 5
BMR 660 Communication Skills I 1
BMR 661 Communication Skills II 1
Total Credit Hours 43
Taken More Than Once *

This program is a five semester program. Coursework is required in the Summer Sessions between Year I and Year II. 

While being trained in clinical trials, participants will develop a strengthened science foundation for application to health-related professional schools.

CTS Core Courses  
Course Number Course Name Credit Hours
CTS 600 Epidemiology and Biostatistics Used in Medical Research 3
CTS 614 Online Survey Tools, Relational and Data Warehousing and Data Manipulation 3
CTS 620 Basic Clinical Research Operations 3
CTS 640* Clinical Trials Journal Club* (x2) 1
CTS 660 Molecular Phenotype of Appalachian Disorders 3
BMR 680* Seminar* (x4) 1
Area of Emphasis in Clinical Research (Health Profession) Courses
CTS 610 OR BMR 617 Study Design and Applied Statistics in Medical Research OR Research Techniques for the Biomedical Sciences 3
CTS 625 Clinical Research Operations Lab 5
BMR 601 Introduction to Nucleic Acids and Proteins 3
BMR 602 Introduction to Cell Structure and Metabolism 3
BMR 603 Regulation of Cell Function 2
BMR 604 Cellular Basis of Disease 1
BMR 882 Research 4
PHS 667 OR PMC 621 Experimental Approaches to Physiology OR Pharmacology I 1
Total Credit Hours 45
Taken More Than Once *

This program is a five semester program. Coursework is required in the Summer Sessions between Year I and Year II. 

Applicants will study the elements of clinical trials while focusing on data manipulation, machine learning, and clinical programming.

CTS Core Courses  
Course Number Course Name Credit Hours
CTS 600 Epidemiology and Biostatistics Used in Medical Research 3
CTS 614 Online Survey Tools, Relational and Data Warehousing and Data Manipulation 3
CTS 620 Basic Clinical Research Operations 3
CTS 640* Clinical Trials Journal Club* (x1) 1
CTS 660 Molecular Phenotype of Appalachian Disorders 3
BMR 680* Seminar* (x2) 1
Area of Emphasis in Clinical Informatics Courses
CTS 610 Study Design and Applied Statistics in Medical Research 3
CTS 611* Machine Learning Journal Club* (x1) 1
CTS 612 Introduction to Clinical Machine Learning 3
CTS 615 Introduction to Clinical Database 3
CTS 616 Introduction to Clinical Programming Using C# 3
CTS 628 Introduction to Java Clinical Programming 4
CTS 630 Fundamentals of Team Science 2
CTS 635 Writing and Peer Review of Scientific Publications 1
CTS 637 Introduction to Tableau 3
CTS 645 Navigating Health IT 3
CTS 650 Rural Clinic Experience 5
BMR 660 Communication Skills I 1
BMR 661 Communications Skills II 1
Total Credit Hours 45
Taken More Than Once *

This program is a five semester program. Coursework is required in the Summer Sessions between Year I and Year II. 

For more information regarding Active Clinical Trials, contact our Medical Director of Clinical Trials - Usha Murughiyan (304) 691-1836.

Active Clinical Trials  
Study ID  PI  Currently Enrolling  Description  Contact Information 
NCT03971071
Ferguson Yes A Phase 4, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache (AMGEN) Sara Runyon
NCT03012776 Phan  Yes A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS™ System. (TOPS IDE) Sara Runyon 
NCT04032093 Keblawi No A Phase 2B Placebo-Controlled, Randomized Study of a Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Women   Mallori Scarberry
NCT03781791 Shivkumar  No Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Sara Runyon
NCT03926130 Sundaram  Yes A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease (VIVID-1 AMAM)  Nicole Finley 
NCT04110145 Shields; Villa Yes A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Sequential, Ascending, Multidose Study to Evaluate the Safety and Efficacy of Linaclotide in Pediatric Participants (Age 2 to 5 Years) with Functional Constipation (LIN-67) Mallori Scarberry
NCT04026113 Shields; Villa Yes A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled,Parallel-group, Safety and Efficacy Study of Linaclotide Administered Orally to Children, Ages 6 to 17 Years, With Functional Constipation (FC) LIN-64 Mallori Scarberry
NCT04329780 Nease Yes A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastric Bypass and Sleeve Gastrectomy (Retro Bariatric Daniell Gallagher
NCT04140305 Ferguson  Yes A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063) Sara Runyon
NCT04173273 Sundaram  Yes  A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease (CULTIVATE) Nicole Finley 
NCT03996369 Sundaram  Yes Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 12) Nicole Finley 
NCT03945188 Sundaram  Yes Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 52) Nicole Finley 
NCT03616821 Sundaram Yes An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis [EXPEDITION] Nicole Finley
NCT03950232 Sundaram Yes An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC OLE) Nicole Finley
NCT03537508 Shields  Yes Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US (MET 42) Mallori Scarberry
NCT03759288 Sundaram Yes An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease (Intrepid)  Nicole Finley
NCT04166058 Shields; Villa Yes; By Invitation Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C Mallori Scarberry
NCT04424316 Keblawi Yes A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy. (MATISSE) Mallori Scarberry
NCT04396236 Lopez Yes A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1) Mallori Scarberry
NCT04396574 Lopez Yes A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2) Mallori Scarberry
NCT04032093 Keblawi Yes A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN Mallori Scarberry
NCT04506190 Nease Yes A Prospective Multicenter Study to Evaluate the Perioperative Outcomes of Laparoscopic and Robotic-assisted Revisional Bariatric Surgery (ISI-dVBAR-002) Mallori Scarberry
Protocol I5Q-MC-B004 Ferguson Yes Preventive Treatment of migraine: Outcomes for Patients in real-world Healthcare systems (TRIUMPH) Daniell Gallagher; Sara Runyon 
TP-201920 Gentile  Yes An Observational Study to Gather Real-World Data on the Tyber Medical Trauma Screw System Daniell Gallagher
RSV-MAT-009 Keblawi  Yes A Phase III, randomized, double-blind, placebocontrolled multi-country study to demonstrate efficacy of a single dose of unadjuvanted RSV Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated LRTI in their infants up to 6 months of age (GRACE) Sara Runyon 
P255-501 Lopez Yes A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy® XR in the Prevention of Migraine in Children 6 to 11 Years of Age Daniell Gallagher

Updated on April 20, 2021.

For more information on PI Initiated Clinical Trials, contact our Medical Director of Clinical Trials - Usha Murughiyan (304) 691-1836

PI Initiated Clinical Trials  
IRB Number  PI  Description 
827507 Egleton, Richard  NAS 
921118 Cyphert, Holly HERD 2020/2021
GRANT  Sundaram, Uma  NIH COBRE
GRANT  Sundaram, Uma NIH Ro1
GRANT  Sundaram,  Uma  Ro1NET
499630 Koester, Alan AVANTA (SRTMMCP)
463451 Koester, Alan AVANTA (SRTMPIP)

Updated on April 3, 2020.  

Clinical Trials 

  • Clinical Trial Coordinator 
  • Clinical Project Manager 
  • Clinical Recruitment Coordinator 

Clinical Research - Health Professions 

  • Medical School 
  • Pharmacy School 
  • Physician Assistant (PA) School

Clinical Informatics 

  • Data Scientist 
  • Data Warehouse Research Analyst
  • Insurance Outcomes Predictor 

Applications will be considered after the priority deadline until June 30, if openings are available.

Leadership 

Uma Sundaram, MD

Vice Dean, Office of Research & Graduate Education 
Phone: (304) 691-184
sundaramu@marshall.edu

Richard Egleton, PhD

Co-DirectorMU JCESOM Graduate Program 
Phone: (304) 696-3523
egleton@marshall.edu

Marlenea Brand, MPA 

Administrative Director of Graduate Studies 
Phone: (304) 696-7399
brandm@marshall.edu